- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Biochemistry Research International
Volume 2012 (2012), Article ID 832059, 10 pages
doi:10.1155/2012/832059
Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, USA
Received 3 April 2012; Accepted 10 May 2012
Academic Editor: Eun-Kyoung Yim Breuer
Copyright © 2012 Eleftheria Tsakalozou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Eleftheria Tsakalozou, Allison M. Eckman, and Younsoo Bae, “Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells,” Biochemistry Research International, vol. 2012, Article ID 832059, 10 pages, 2012. doi:10.1155/2012/832059